Cargando…
Current Status of Human Papillomavirus-Related Head and Neck Cancer: From Viral Genome to Patient Care
Human papillomavirus (HPV) infection identified as a definitive human carcinogen is increasingly being recognized for its role in carcinogenesis of human cancers. Up to 38%–80% of head and neck squamous cell carcinoma (HNSCC) in oropharyngeal location (OPSCC) and nearly all cervical cancers contain...
Autores principales: | Dong, Haoru, Shu, Xinhua, Xu, Qiang, Zhu, Chen, Kaufmann, Andreas M., Zheng, Zhi-Ming, Albers, Andreas E., Qian, Xu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Singapore
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8692589/ https://www.ncbi.nlm.nih.gov/pubmed/34152564 http://dx.doi.org/10.1007/s12250-021-00413-8 |
Ejemplares similares
-
Advanced Nanomedicine for High-Risk HPV-Driven Head and Neck Cancer
por: Xu, Qiang, et al.
Publicado: (2022) -
Insights into Nanomedicine for Immunotherapeutics in Squamous Cell Carcinoma of the head and neck
por: Xu, Qiang, et al.
Publicado: (2020) -
A Quest for Initiating Cells of Head and Neck Cancer and Their Treatment
por: Chen, Chao, et al.
Publicado: (2010) -
Human papillomavirus in head and neck cancer in India: Current status and consensus recommendations
por: Murthy, Vedang, et al.
Publicado: (2017) -
Taxane-cisplatin-fluorouracil as induction chemotherapy for advanced head and neck cancer: a meta-analysis of the 5-year efficacy and safety
por: Qian, Xu, et al.
Publicado: (2015)